Skip to content
TrialScanner

NCT03812263

A Clinical Trial to Evaluate the Safety and Efficacy of RP-L201 in Subjects With Leukocyte Adhesion Deficiency-I

Phase 1/Phase 2CompletedRCKTLead

Registry record

Lead sponsor
Rocket Pharmaceuticals Inc.
Conditions
Leukocyte Adhesion Defect - Type I
Primary completion
Sep 12, 2023Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03812263 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03812263: A Clinical Trial to Evaluate... | TrialScanner